Cargando…

Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety

INTRODUCTION: Dengue shock syndrome (DSS) fluid resuscitation by following the World Health Organization (WHO) guideline usually required large volumes of Ringer lactate (RL) that might induce secondary fluid overload. Our objective was to compare the effectiveness of the recommended volume of RL ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Somasetia, Dadang H, Setiati, Tatty E, Sjahrodji, Azhali M, Idjradinata, Ponpon S, Setiabudi, Djatnika, Roth, Hubert, Ichai, Carole, Fontaine, Eric, Leverve, Xavier M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172842/
https://www.ncbi.nlm.nih.gov/pubmed/25189175
http://dx.doi.org/10.1186/s13054-014-0466-4
_version_ 1782336082672615424
author Somasetia, Dadang H
Setiati, Tatty E
Sjahrodji, Azhali M
Idjradinata, Ponpon S
Setiabudi, Djatnika
Roth, Hubert
Ichai, Carole
Fontaine, Eric
Leverve, Xavier M
author_facet Somasetia, Dadang H
Setiati, Tatty E
Sjahrodji, Azhali M
Idjradinata, Ponpon S
Setiabudi, Djatnika
Roth, Hubert
Ichai, Carole
Fontaine, Eric
Leverve, Xavier M
author_sort Somasetia, Dadang H
collection PubMed
description INTRODUCTION: Dengue shock syndrome (DSS) fluid resuscitation by following the World Health Organization (WHO) guideline usually required large volumes of Ringer lactate (RL) that might induce secondary fluid overload. Our objective was to compare the effectiveness of the recommended volume of RL versus a smaller volume of a hypertonic sodium lactate solution (HSL) in children with DSS. The primary end point was to evaluate the effect of HSL on endothelial cell inflammation, assessed by soluble vascular cell adhesion molecule-1 (sVCAM-1) measurements. Secondarily, we considered the effectiveness of HSL in restoring hemodynamic fluid balance, acid–base status, and sodium and chloride balances, as well as in-hospital survival. METHODS: A prospective randomized single-blind clinical trial including 50 DSS children was conducted in the Pediatrics Department of Hasan Sadikin Hospital, Bandung, Indonesia. Only pediatric patients (2 to 14 years old) fulfilling the WHO criteria for DSS and new to resuscitation treatments were eligible. Patients were resuscitated with either HSL (5 ml/kg/BW in 15 minutes followed by 1 ml/kg/BW/h for 12 hours), or RL (20 ml/kg/BW in 15 minutes followed by decreasing doses of 10, 7, 5, and 3 ml/kg BW/h for 12 hours). RESULTS: In total, 50 patients were randomized and included in outcome and adverse-event analysis; 46 patients (8.2 ± 0.5 years; 24.9 ± 1.9 kg; mean ± SEM) completed the protocol and were fully analyzed (24 and 22 subjects in the HSL and RL groups, respectively). Baseline (prebolus) data were similar in both groups. Hemodynamic recovery, plasma expansion, clinical outcome, and survival rate were not significantly different in the two groups, whereas fluid accumulation was one third lower in the HSL than in the RL group. Moreover, HSL was responsible for a partial recovery from endothelial dysfunction, as indicated by the significant decrease in sVCAM-1. CONCLUSION: Similar hemodynamic shock recovery and plasma expansion were achieved in both groups despite much lower fluid intake and fluid accumulation in the HSL group. TRIAL REGISTRATION: ClinicalTrials.gov NCT00966628. Registered 26 August 2009.
format Online
Article
Text
id pubmed-4172842
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41728422014-09-25 Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety Somasetia, Dadang H Setiati, Tatty E Sjahrodji, Azhali M Idjradinata, Ponpon S Setiabudi, Djatnika Roth, Hubert Ichai, Carole Fontaine, Eric Leverve, Xavier M Crit Care Research INTRODUCTION: Dengue shock syndrome (DSS) fluid resuscitation by following the World Health Organization (WHO) guideline usually required large volumes of Ringer lactate (RL) that might induce secondary fluid overload. Our objective was to compare the effectiveness of the recommended volume of RL versus a smaller volume of a hypertonic sodium lactate solution (HSL) in children with DSS. The primary end point was to evaluate the effect of HSL on endothelial cell inflammation, assessed by soluble vascular cell adhesion molecule-1 (sVCAM-1) measurements. Secondarily, we considered the effectiveness of HSL in restoring hemodynamic fluid balance, acid–base status, and sodium and chloride balances, as well as in-hospital survival. METHODS: A prospective randomized single-blind clinical trial including 50 DSS children was conducted in the Pediatrics Department of Hasan Sadikin Hospital, Bandung, Indonesia. Only pediatric patients (2 to 14 years old) fulfilling the WHO criteria for DSS and new to resuscitation treatments were eligible. Patients were resuscitated with either HSL (5 ml/kg/BW in 15 minutes followed by 1 ml/kg/BW/h for 12 hours), or RL (20 ml/kg/BW in 15 minutes followed by decreasing doses of 10, 7, 5, and 3 ml/kg BW/h for 12 hours). RESULTS: In total, 50 patients were randomized and included in outcome and adverse-event analysis; 46 patients (8.2 ± 0.5 years; 24.9 ± 1.9 kg; mean ± SEM) completed the protocol and were fully analyzed (24 and 22 subjects in the HSL and RL groups, respectively). Baseline (prebolus) data were similar in both groups. Hemodynamic recovery, plasma expansion, clinical outcome, and survival rate were not significantly different in the two groups, whereas fluid accumulation was one third lower in the HSL than in the RL group. Moreover, HSL was responsible for a partial recovery from endothelial dysfunction, as indicated by the significant decrease in sVCAM-1. CONCLUSION: Similar hemodynamic shock recovery and plasma expansion were achieved in both groups despite much lower fluid intake and fluid accumulation in the HSL group. TRIAL REGISTRATION: ClinicalTrials.gov NCT00966628. Registered 26 August 2009. BioMed Central 2014-09-05 2014 /pmc/articles/PMC4172842/ /pubmed/25189175 http://dx.doi.org/10.1186/s13054-014-0466-4 Text en © Somasetia et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Somasetia, Dadang H
Setiati, Tatty E
Sjahrodji, Azhali M
Idjradinata, Ponpon S
Setiabudi, Djatnika
Roth, Hubert
Ichai, Carole
Fontaine, Eric
Leverve, Xavier M
Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety
title Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety
title_full Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety
title_fullStr Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety
title_full_unstemmed Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety
title_short Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety
title_sort early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172842/
https://www.ncbi.nlm.nih.gov/pubmed/25189175
http://dx.doi.org/10.1186/s13054-014-0466-4
work_keys_str_mv AT somasetiadadangh earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT setiatitattye earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT sjahrodjiazhalim earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT idjradinataponpons earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT setiabudidjatnika earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT rothhubert earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT ichaicarole earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT fontaineeric earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety
AT levervexavierm earlyresuscitationofdengueshocksyndromeinchildrenwithhyperosmolarsodiumlactatearandomizedsingleblindclinicaltrialofefficacyandsafety